Adds glucose-6-phosphate dehydrogenase or G6PD deficiency to the list of required neonatal screenings.
BILL NUMBER: S2327
TITLE OF BILL :
An act to amend the public health law, in relation to neonatal testing for glucose-6-phosphate dehydrogenase (G6PD deficiency)
To provide life saving information for parents of newborn children.
SUMMARY OF PROVISIONS :
This bill would amend subdivision (a) of the Public Health Law,
§2500-a to add glucose-6-phosphate dehydrogenase (G6PD) deficiency to the list of conditions for which newborn infants must be tested by hospitals or other institutions caring for infants less than 28 days of age.
G6PD deficiency can be a life threatening condition if not carefully managed. This common human enzyme deficiency afflicts an estimated 400 million people worldwide. The lack of this enzyme can cause anemia and other adverse symptoms. The severity of the pathologies associated with this deficiency has prompted a great deal of research and new treatment techniques are being developed. Early detection of G6PD deficiency would promote early intervention to avoid potentially serious risks through educational and social programs including a regimen of special diet.
LEGISLATIVE HISTORY :
S.1145/A.6568 of 2007-08 (3rd Reading 2008); S.1214/A.2358 in 2005-06 (Reported to Senate Rules 2006); S.6551/A.9905 in 2004 (Reported to Senate Rules Committee).
FISCAL IMPLICATIONS :
Undetermined. However, such cost should be minimal in comparison to the costs associated with medical care necessary to treat those in whom the disease has caused pathologies because they have been unaware of this enzyme deficiency.
EFFECTIVE DATE : 180th day following enactment; provided that the promulgation of rules or regulations needed for implementation could be enacted prior to such date.
STATE OF NEW YORK ________________________________________________________________________ 2327 2009-2010 Regular Sessions IN SENATE February 18, 2009 ___________Introduced by Sen. PADAVAN -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to neonatal testing for glucose-6-phosphate dehydrogenase (G6PD deficiency) THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision (a) of section 2500-a of the public health law, as amended by chapter 863 of the laws of 1986, is amended to read as follows: (a) It shall be the duty of the administrative officer or other person in charge of each institution caring for infants twenty-eight days or less of age and the person required in pursuance of the provisions of section forty-one hundred thirty of this chapter to register the birth of a child, to cause to have administered to every such infant or child in its or his care a test for phenylketonuria, homozygous sickle cell disease, hypothyroidism, branched-chain ketonuria, galactosemia, homo- cystinuria, GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD DEFICIENCY) and such other diseases and conditions as may from time to time be designated by the commissioner in accordance with rules or regulations prescribed by the commissioner. Testing, the recording of the results of such tests, tracking, follow-up reviews and educational activities shall be performed at such times and in such manner as may be prescribed by the commissioner. The commissioner shall promulgate regulations setting forth the manner in which information describing the purposes of the requirements of this section shall be disseminated to parents or a guar- dian of the infant tested. S 2. This act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addition, amend- ment and/or repeal of any rule or regulation necessary for the implemen- tation of this act on its effective date is authorized and directed to be made and completed on or before such effective date.EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD08649-01-9